Last deal

Amount

Venture - Series Unknown

Stage

01.01.2018

Date

3

all rounds

$167M

Total amount

Financing round

General

About Company
ARMO Biosciences is a biotech company that develops immune modulatory biologic therapeutics.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2013

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

The California-based company is focused on developing a pipeline of products that activate the immune system of cancer patients to recognize and eradicate tumors. Its lead product candidate, AM0010, stimulates the survival, expansion, and killing potential of CD8+ T cells, which recognize and kill cancer cells. ARMO Biosciences is also developing an anti-PD-1 monoclonal antibody to treat a variety of cancers in combination with standard of care treatments and emerging immunotherapies.
Contacts

Social url

Similar Companies
1000
Coherus Biosciences

Coherus Biosciences

Coherus Biosciences develops and sells biologic therapeutics for oncology and inflammatory diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Redwood City, CA, USA

total rounds

16

total raised

$1.27B
Catena Biosciences

Catena Biosciences

Catena Biosciences is a biotech startup that develops advanced protein coupling technology to cure autoimmune disorders.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Berkeley, CA, USA

total rounds

4

total raised

$7.35M
Bird Rock Bio

Bird Rock Bio

Bird Rock Bio develops innovative immuno-inflammatory regulators for medical institutions in China.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

La Jolla, San Diego, CA, USA

total rounds

8

total raised

$77.5M
Abogen Biosciences

Abogen Biosciences

Abogen Biosciences is a biotech company that develops RNA and DNA therapeutics for cancer and infectious diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Pharmaceuticals, Therapeutics

Location

Suzhou, Jiangsu, China

total rounds

6

total raised

$1.41B

count Of Investments

1
M&A Details
1

Transaction name

Acquired by

Eli Lilly

announced date

10.05.2018

price

$1.6B

Financials

Funding Rounds
6
3

Number of Funding Rounds

$167M

Money Raised

Their latest funding was raised on 01.01.2018. Their latest investor GV. Their latest round Venture - Series Unknown

Kleiner Perkins

Kleiner Perkins

Kleiner Perkins is a venture capital firm that invests in early-stage, incubation and growth companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Menlo Park, CA, USA

count Of Investments

1051

count Of Exists

261
Sequoia Capital

Sequoia Capital

Sequoia is a venture capital firm that helps daring founders build legendary companies from idea to IPO and beyond.

Sector

General Industrials

Subsector

Diversified Industrials

Location

Menlo Park, CA, USA

count Of Investments

1967

count Of Exists

319
DAG Ventures

DAG Ventures

DAG Ventures is a US-based venture capital firm that invests in early and growth-stage tech companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Finance

Location

Palo Alto, CA, USA

count Of Investments

183

count Of Exists

86
Qiming Venture Partners

Qiming Venture Partners

Qiming Venture Partners is a leading China-based venture capital firm that invests in technology, consumer, and healthcare companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Finance

Location

Shanghai, China

count Of Investments

891

count Of Exists

28
RTW Investments LLC

RTW Investments LLC

RTW Investments is an innovative health care investment firm.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Venture Capital, Financial Services, Health Care

Location

New York, NY, USA

count Of Investments

90

count Of Exists

3
OrbiMed

OrbiMed

OrbiMed is a healthcare-focused investment firm managing approximately $5 billion in assets.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Venture Capital, Health Care

Location

New York, NY, USA

count Of Investments

561

count Of Exists

82
HBM Healthcare Investments AG

HBM Healthcare Investments AG

HBM Healthcare Investments finances companies in the medical and biotech sectors.

Sector

Open End and Miscellaneous Investment Vehicles

Subsector

Open End and Miscellaneous Investment Vehicles

Keywords

Medical, Biotechnology, Venture Capital

Location

Zug, Switzerland

count Of Investments

204

count Of Exists

32
Celgene

Celgene

Celgene develops and sells innovative therapies for cancer and immune-inflammatory diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Summit, NJ, USA

count Of Investments

44

count Of Exists

12
Co-Investors
Investors
14
8

Number of lead investors

14

Number of investors

Investor 
Lead 
Round 
Partners 
No
Series C
No
Venture - Series Unknown
GV

GV

GV is a venture capital firm that provides funding to innovative startups in various fields.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Mountain View, CA, USA

count Of Investments

820

count Of Exists

169
Frazier Healthcare Partners

Frazier Healthcare Partners

Frazier Healthcare Partners is a private equity firm that provides growth and venture capital to healthcare companies.

Sector

Open End and Miscellaneous Investment Vehicles

Subsector

Open End and Miscellaneous Investment Vehicles

Keywords

Health Care, Venture Capital, Financial Services

Location

Seattle, WA, USA

count Of Investments

167

count Of Exists

57
Clough Capital Partners

Clough Capital Partners

Clough Capital Partners is a global investment management firm.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Finance, Venture Capital

Location

Boston, MA, USA

count Of Investments

11

count Of Exists

4

People

Founders
2

Martin Oft

Martin Oft, MD has over 19 years of experience in Biotechnology and Pharmaceutical Research and Development. Most recently he co-founded ARMO to develop immune therapies for the treatment of cancer and other diseases. Prior to ARMO, Martin held positions at DNAX Research Inc. of Schering Plough in Palo Alto, now Merck Research Labs. There, he led multiple development teams to progress immune therapies for the treatment of cancer and led the efforts for the discovery and development of PEGylated IL-10. Previously, Martin served at Onyx Pharmaceuticals, the UCSF Cancer Center, and Boehringer Ingelheim. Martin holds an MD degree and medical license from the University of Erlangen, Germany. He performed his postdoctoral research at the Institute of Molecular Pathology in Vienna, Austria. Martin published numerous scientific articles and reviews on cancer progression and the immune response to cancer and he is an inventor on a number of cancer therapy patents.

current job

Synthekine
Synthekine

organization founded

1

Martin Oft

John Mumm
John Mumm

John Mumm

Biotechnology entrepreneur - focusing on developing cytokines for treatment of disease

current job

Deka Biosciences
Deka Biosciences

organization founded

2

John Mumm

Employee Profiles
3
Peter Van Vlasselaer

Peter Van Vlasselaer

CEO

Activity

Recent News
0